Lovastatin Down Regulates the Expression of Lectin-like Oxidized Low Density Lipoprotein Receptor (LOX) 1 mRNA on Human Umbilical Vein Endothelial Cells

全智华,李全忠,邓衡,易光辉,杨永宗

DOI: https://doi.org/10.3969/j.issn.1007-3949.2002.01.008

2002-01-01

Abstract:Aim To investigate whether statins alter the expression of lectin-like oxidized low density lipoprotein receptor (LOX) 1 mRNA and uptake of oxidized low density lipoprotein on cultured human umbilical vein endothelial cells (hUVEC). Methods Total RNA was extracted with Trizol reagent. Reverse transcription polymerase chain reaction (RT-PCR) was used to quantify mRNA expression of LOX-1 in hUVEC. Ox-LDL was radioiodinated with 125 I to detect the uptake of ox-LDL by endothelial cells. A spectrophotometric enzyme assay was performed to determine the activity of LDH.Results LOX-1 mRNA expression was significantly suppressed to 84%,69% and 48% of control after hUVEC were incubated with 1,10,50 μmol/L of lovastatin for 48 h. LOX-1 mRNA expression was significantly suppressed to 82%,69% and 52% of control in the cells treated with lovastatin after 24,48 or 96 h respectively. Conclusion Lovastatin reduces the expression of LOX-1 mRNA and uptake of ox-LDL without any toxic effects which may contribute to the antiatherosclerotic potential of lovastatin.